Published in Blood Weekly, May 18th, 2006
"Recent data have indicated that estradiol can modulate the kinetics of EPCs via eNOS-dependent mechanisms. We hypothesized that estradiol could augment the incorporation of BM-derived EPCs into sites of ischemia-induced neovascularization, resulting in protection from ischemic injury," wrote A. Iwakura and colleagues, Tufts...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.